In addition, even antigen-naïve animals often express “natural antibodies ... thus permitting the construction of immune complexes for presentation before the development of acquired ...

Invenra has launched its Rapid Antibody Discovery Service, designed to simplify and de-risk the preclinical development of ...

YUMAB’s antibody discovery and development ... but great effort is being channeled into targeting more complex and difficult antigens, such as multimembrane-spanning receptors, receptor ...

Determining how to predict the antibody-antigen interactions was the biggest challenge. The researchers focused on the ...

Novel vaccine platform improved protection against diverse influenza subtypes when tested in animal models and human ...

Earlier this year, Crossbow Therapeutics Inc. announced the nomination of its first development candidate, CBX-250, a TCR-mimetic (TCRm) bispecific T-cell engager (TCE) antibody targeting a CTSG ...

Recent developments highlight the potential of antibody-drug conjugates ... responses against tumor-specific antigens presented by major histocompatibility complexes (MHC). These methods ...

The patient's sample is added to the port, where antibodies targeting the virus fusion protein can bind the antigen in the sample. Capillary action migrates the resultant complex along the strip ...

While it's known that major histocompatibility complex class I (MHC ... the body's immune system to produce antibodies—and explore ways to use the antigens to elicit immune responses.

Most people who get the seasonal influenza vaccine – which contains strains of viruses from distinct virus subtypes – mount a strong immune response to one strain, leaving them vulnerable to infection ...